Tatsuyuki Onodera
Jikei University School of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tatsuyuki Onodera.
Journal of Cardiac Failure | 1998
Kazuaki Horikoshi; Makoto Nagai; Shingo Seki; Tatsuyuki Onodera; T Arino; M Isiki; Seibu Mochizuki
The purpose of this study was to examine activator protein-1 (AP1) and nuclear factor-KB (NF-KB) DNA binding activity, which seem to be important in a signal transduction cascade upstream of the increased level of mRNA expression observed in isoproterenol-induced left ventricular hypertrophy. Rats were continuously infused with saline and low or high dose of isoproterenol (0.5 or 3 mg/kg/day) by an osmotic minipump for 12 hr, 24 hr, 48 hr or 72 hr.AP-1 and NF-KB DNA binding activity was determined using an electrophoretic mobility shift assay. Levels of ANP and c~-skeletal actin mRNAs were analyzed by Northern bJot hybridization. AP-1 DNA binding activities by low or high dose of [soproterenol administration were increased at 12 hr, reached their peak 24.1and 37.1-fold (P<0.01) at 24 hr, and thereafter declined. Although N F-KB DNA binding activities by low dose of isoprotenol did not change, it by high dose increased to 6.0-fold (P<0.01) at 48 hr. Moreover, levels of ANP and c~skeletal actin mRNAs increased 8.0and 3.5-fold (P<0.01) by low dose, and 14.3and 6.2-fold (P<0.01) by high dose at 48 hr. Isoproterenol by high dose induced severe hypertrophy of myocyte and necrosis by histological examination. NF-KB DNA binding activities may be induced by an inflammatory response following myocardial injury. On the other hand, AP-1 DNA binding activity peaked at day1 in both low dose and high dose and levels of ANP and c~-skeltal actin mRNAs peaked at day 2. AP-1 DNA binding activity intially increased followed by increased expression of ANP and c~-skeletal actin mRNAs and these signal transduction mechasism may contribute to the isoproterenolinduced hypertrophy.
Hypertension Research | 2002
Tatsuyuki Onodera; Fumiko Okazaki; Hidekazu Miyazaki; Shunrou Minami; Takashi Ito; Shingo Seki; Masayuki Taniguchi; Ikuo Taniguchi; Seibu Mochizuki
Molecular and Cellular Biochemistry | 1993
Seibu Mochizuki; Shingo Seki; Masaaki Ejima; Tatsuyuki Onodera; Masayuki Taniguchi; Shinichiro Ishikawa
International Heart Journal | 2006
Shunrou Minami; Tatsuyuki Onodera; Fumiko Okazaki; Hidekazu Miyazaki; Shingo Ohsawa; Seibu Mochizuki
Hypertension Research | 2003
Shingo Seki; Makoto Nagai; Hiroshi Takeda; Tatsuyuki Onodera; Fumiko Okazaki; Masayuki Taniguchi; Ikuo Taniguchi; Seibu Mochizuki
Japanese Circulation Journal-english Edition | 2004
Tatsuo Yamazaki; Ikuo Taniguchi; Takashi Kurusu; Yoshihisa Shimazu; Yoshiyuki Hashizume; Kazutoshi Takikawa; Masao Kuwata; Tatsuyuki Onodera; Makoto Yoshikawa; Seibu Mochizuki
Japanese Circulation Journal-english Edition | 2002
Shingo Seki; Hiroshi Takeda; Makoto Nagai; Tatsuyuki Onodera; Masayuki Taniguchi; Ikuo Taniguchi; Seibu Mochizuki
The Jikei University School of Medicine | 2006
Takashi Ito; Ikuo Taniguchi; Makoto Nagai; Yuichi Saito; Satoshi Imamoto; Mamoru Kuno; Tatsuyuki Onodera; Shingo Seki; Masayuki Taniguchi
Japanese Circulation Journal-english Edition | 2002
Masayuki Taniguchi; Makoto Nagai; Tatsuyuki Onodera; Shingo Seki; Ikuo Taniguchi; Seibu Mochizuki
Journal of Molecular and Cellular Cardiology | 2001
Tatsuyuki Onodera; Hidekazu Miyazaki; Fumiko Okazaki; Shunrou Minami; Shingo Seki; Masayuki Taniguchi; Ikuo Taniguchi; Seibu Mochizuki